scholarly journals Fetal atrial flutter and supraventricular tachycardia

2019 ◽  
Vol 45 ◽  
pp. S47
Author(s):  
Joanna Dangel
Keyword(s):  
Atrial Flutter ◽  
Supraventricular Tachycardia

scholarly journals Supraventricular Tachycardia With Underlying Atrial Flutter in a Diabetic Ketoacidosis Patient

2015 ◽  
Vol 33 (3) ◽  
pp. 146-149 ◽  
Author(s):  
Taha A. Faruqi ◽  
Usama A. Hanhan ◽  
James P. Orlowski ◽  
Katie S. Laun ◽  
Andrew L. Williams ◽  
...  
Keyword(s):  
Diabetic Ketoacidosis ◽  
Atrial Flutter ◽  
Supraventricular Tachycardia

Supraventricular Tachycardia

2020 ◽  
Author(s):  
Laurence M. Epstein ◽  
Saurabh Kumar
Keyword(s):  
Atrial Flutter ◽  
Supraventricular Tachycardia ◽  
Cardiac Tissue ◽  
Accessory Pathway ◽  
Maze Procedure ◽  
Atrioventricular Nodal Reentrant Tachycardia ◽  
Reentrant Tachycardia ◽  
Inappropriate Sinus Tachycardia ◽  
Atrioventricular Reentrant Tachycardia ◽  
Supraventricular Tachycardias

Supraventricular tachycardias (SVTs) comprise a group of usually benign arrhythmias that originate from cardiac tissue at or above the His bundle. SVTs include inappropriate sinus tachycardia, atrial tachycardias (ATs), atrial flutter (AFL), junctional tachycardia, atrioventricular nodal reentrant tachycardia (AVNRT), and forms of accessory pathway–mediated reentrant tachycardias (atrioventricular reentrant tachycardia [AVRT]). Although mostly benign, symptoms can be debilitating, in the form of palpitations, shortness of breath, chest discomfort, dizziness, and/or syncope; rarely, SVTs can result in cardiomyopathy due to incessant arrhythmia. This review covers the epidemiology, diagnosis, management, and classification of SVTs.  This review contains 14 figures, 17 tables, and 61 references. Keywords: Supraventricular tachycardia, cardioversion, arrhythmia, atrial flutter, atrial fibrillation, Wolff-Parkinson-White syndrome, MAZE procedure, catheter ablation

Atrial Fibrillation and Other Cardiac Arrhythmias (DRAFT)

2018 ◽  
Author(s):  
Antoine Schneider ◽  
Rinaldo Bellomo
Keyword(s):  
Atrial Fibrillation ◽  
Ventricular Tachycardia ◽  
Atrial Flutter ◽  
Supraventricular Tachycardia ◽  
Cardiac Arrhythmias ◽  
Older Patients ◽  
Hospital Setting ◽  
Rapid Response Team ◽  
Hospitalized Patients ◽  
Response Team

Cardiac arrhythmias are common in hospitalized patients, with their incidence increasing in older patients and those with comorbidities. Cardiac arrhythmias represent a trigger for approximately 10% of rapid response team (RRT) activations. Of those, atrial fibrillation (AF) is the most commonly observed. Other common cardiac arrhythmias in the in-hospital setting include supraventricular tachycardia, atrial flutter, ventricular tachycardia, and bradycardias. Members of the RRT should be skilled in the diagnosis and management of these common arrhythmias. This chapter presents an overview of cardiac arrhythmias that RRT members are likely to encounter, discussing their incidence and significance, as well as their immediate management.

Neonatal Tachyarrhythmias

2000 ◽  
Vol 19 (7) ◽  
pp. 45-51
Author(s):  
Margaret Watson
Keyword(s):  
Atrial Flutter ◽  
Supraventricular Tachycardia ◽  
Cardiac Arrhythmias ◽  
Heart Block ◽  
Ventricular Arrhythmias ◽  
Sinus Bradycardia

CARDIAC ARRHYTHMIAS CAN BE found in the fetus and the neonate. Arrhythmias that are seen in the neonate include sinus bradycardia and tachycardia, premature atrial and ventricular contractions, supraventricular tachycardia, atrial flutter, ventricular arrhythmias, and heart block. Although infants with structural or functional anomalies can have arrhythmias, many arrhythmias result from noncardiac causes, such as hypoxemia and acidosis.1

Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment

2011 ◽  
Vol 22 (4) ◽  
pp. 372-380 ◽  
Author(s):  
Orhan Uzun ◽  
Kadir Babaoglu ◽  
Anju Sinha ◽  
Spyridon Massias ◽  
Bryan Beattie
Keyword(s):  
Sinus Rhythm ◽  
Atrial Flutter ◽  
Supraventricular Tachycardia ◽  
Combination Treatment ◽  
Serum Levels ◽  
Response To Treatment ◽  
Intrauterine Death ◽  
Tertiary Referral Centre ◽  
Rapid Control ◽  
Postnatal Outcome

AbstractObjectivesTo evaluate the efficacy of flecainide and digoxin combination in foetal supraventricular tachycardia.SettingThis study was carried out in a tertiary referral centre.MethodsWe conducted a retrospective review of 29 patients diagnosed with supraventricular foetal tachycardia between 2001 and 2009. Mode of presentation, foetal cardiac function, maternal anti-arrhythmic serum levels, drug tolerance, and maternal electrocardiogram recordings were assessed. The postnatal outcome of each infant was also evaluated for tachycardia recurrence.ResultsIn all, 27 foetuses were treated with digoxin and flecainide combination, and two foetuses were delivered without any treatment. Of the 27 foetuses, seven had atrial flutter and the remaining 22 had atrioventricular re-entry tachycardia. There were eight foetuses with hydrops (27%), of whom three had atrial flutter and five had atrioventricular re-entry tachycardia; 26 foetuses (96%) responded to flecainide and digoxin combination, with restoration of sinus rhythm in 22 (81.4%) and rate control in the other four. In one severely hydropic foetus, there was no response to treatment. In all, 26 treated infants were delivered alive, but one pregnancy was terminated for non-cardiac causes when the foetus was in sinus rhythm. There was no intrauterine death due to tachycardia. Although there were minor side effects to anti-arrhythmic medications, none of the pregnant women developed proarrhythmia.ConclusionFlecainide and digoxin combination treatment offers a safe and effective treatment for foetal supraventricular tachycardia with fast restoration of sinus rhythm.

The combined use of amiodarone and class 1-C antiarrhythmic agents in children with intractable supraventricular tachyarrhythmias

1995 ◽  
Vol 5 (1) ◽  
pp. 70-74 ◽  
Author(s):  
Seshadri Balaji ◽  
Christopher L. Case ◽  
Paul C. Gillette
Keyword(s):  
Atrial Flutter ◽  
Supraventricular Tachycardia ◽  
Combined Therapy ◽  
Antiarrhythmic Agents ◽  
Reentrant Tachycardia ◽  
Fontan Patient ◽  
Atrioventricular Reentrant Tachycardia ◽  
Combined Use ◽  
Class 1 ◽  
Atrial Ectopic Tachycardia

AbstractCombined antiarrhythmic drug therapy is an occasionally necessary but problematic approach to the child with recalcitrant supraventricular tachycardia. There is little experience with the combined use of amiodarone and class 1-C agents (flecainide, propafenone and encainide) in children. To judge the efficacy and safety of this combination, we reviewed the case notes and results of investigation in all nine children with supraventricular tachycardia who received such therapy between 1984 and 1993. These nine children received combined therapy on 12 occasions. Five were infants with either atrioventricular reentrant tachycardia (n=3) or atrial ectopic tachycardia (n=2), and four were older children with atrial flutter seen after a Fontan procedure. Amiodarone was combined with flecainide on eight occasions, with propafenone on three occasions, and with encainide on one occasion. Both infants with atrial ectopic tachycardia were successfully controlled, but only one of three infants with atrioventricular reentrant tachycardia had successful control on combination therapy. In three of the four patients with atrial flutter, the combination was useful in reducing the number of arrhythmic episodes. Three infants suffered side effects. At electrophysiologic study to judge efficacy, ventricular tachycardia was induced in two patients (one infant and one Fontan patient), necessitating a change in the 1-C agent. One patient had skin rash due to flecainide and was placed on propafenone with success. One Fontan patient died of complications after an elective surgical procedure. No deaths occurred attributable to proarrhythmia. Thus, combined therapy with amiodarone and 1-C agents was found to be safe and fairly effective in children with certain types of intractable supraventricular tachycardia.

scholarly journals Atypical response of class IC atrial flutter to adenosine

2015 ◽  
Vol 76 (3) ◽  
Author(s):  
Francesco Rotondi ◽  
Tonino Lanzillo ◽  
Fiore Manganelli ◽  
Francesca Lanni ◽  
Ferdinando Alfano ◽  
...  
Keyword(s):  
Sinus Rhythm ◽  
Atrial Flutter ◽  
Supraventricular Tachycardia ◽  
Ventricular Rate ◽  
Qrs Complex ◽  
Intravenous Amiodarone ◽  
Adenosine Administration ◽  
Ventricular Conduction

We report the case of a 67-year-old female with a wide QRS complex tachycardia at 180 bpm. A diagnosis of class IC atrial flutter with aberrant ventricular conduction caused by flecainide therapy was formulated. Intravenous adenosine administration resulted in adequate slowing of the ventricular rate and normalization of QRS complexes. Restoration of sinus rhythm was achieved with intravenous amiodarone. The response to adenosine confirmed the diagnosis of supraventricular tachycardia with aberrant conduction, but the transition from arrhythmia onset to restoration of sinus rhythm showed interesting peculiarities.

Introduction to the Electrophysiology Manual: Fluoroscopic Views, Electrograms, and Relevant Anatomy

2013 ◽  
pp. 3-64
Author(s):  
Samuel J. Asirvatham
Keyword(s):  
Atrial Fibrillation ◽  
Ventricular Tachycardia ◽  
Atrial Flutter ◽  
Supraventricular Tachycardia ◽  
Catheter Position ◽  
Display Format ◽  
The Common

The purpose of this chapter is to familiarize the reader with the typical fluoroscopic views and electrograms used throughout this book. First, the rationale for the particular views used and the standard electrogram display format are introduced. The discussion then continues to the important fluoroscopic landmarks relevant to the arrhythmias encountered in the electrophysiology laboratory. These landmarks are discussed in the context of the electrograms obtained from mapping these sites and their importance from an anatomic and ablation standpoint. The first topics are the common fluoroscopic and anatomic principles relevant to the electrophysiology laboratory; then the specific differences in catheter use and electrograms obtained from the standard fluoroscopic catheter position in supraventricular tachycardia, atrial flutter, atrial fibrillation, and ventricular tachycardia; and finally some unusual positions and congenital variants.

Sign in / Sign up

Export Citation Format

Share Document